Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biochem Mol Biol Educ ; 46(1): 91-97, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28782152

RESUMEN

This article describes a simple exercise using a free, easy-to-use, established online program. The exercise helps to reinforce protein purification concepts and introduces undergraduates to pH as a parameter that affects anion-exchange chromatography. The exercise was tested with biochemistry majors at California State University-Chico. Given the versatility of the program, this work is also a model for instructors that wish to develop their own exercise to help teach other protein purification techniques. © 2017 by The International Union of Biochemistry and Molecular Biology, 46(1):91-97, 2018.


Asunto(s)
Bioquímica/educación , Cromatografía por Intercambio Iónico/métodos , Proteínas/aislamiento & purificación , Enseñanza , Concentración de Iones de Hidrógeno , Internet , Proteínas/química , Estudiantes , Universidades
3.
Nat Chem Biol ; 11(9): 625-31, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26284661
4.
J Biol Chem ; 289(49): 34114-28, 2014 Dec 05.
Artículo en Inglés | MEDLINE | ID: mdl-25342744

RESUMEN

The human pathogen Shigella flexneri subverts host function and defenses by deploying a cohort of effector proteins via a type III secretion system. The IpaH family of 10 such effectors mimics ubiquitin ligases but bears no sequence or structural homology to their eukaryotic counterpoints. Using rates of (125)I-polyubiquitin chain formation as a functional read out, IpaH9.8 displays V-type positive cooperativity with respect to varying concentrations of its Ubc5B∼(125)I-ubiquitin thioester co-substrate in the nanomolar range ([S]½ = 140 ± 32 nm; n = 1.8 ± 0.1) and cooperative substrate inhibition at micromolar concentrations ([S]½ = 740 ± 240 nm; n = 1.7 ± 0.2), requiring ordered binding to two functionally distinct sites per subunit. The isosteric substrate analog Ubc5BC85S-ubiquitin oxyester acts as a competitive inhibitor of wild-type Ubc5B∼(125)I-ubiquitin thioester (Ki = 117 ± 29 nm), whereas a Ubc5BC85A product analog shows noncompetitive inhibition (Ki = 2.2 ± 0.5 µm), consistent with the two-site model. Re-evaluation of a related IpaH3 crystal structure (PDB entry 3CVR) identifies a symmetric dimer consistent with the observed cooperativity. Genetic disruption of the predicted IpaH9.8 dimer interface reduces the solution molecular weight and significantly ablates the kcat but not [S]½ for polyubiquitin chain formation. Other studies demonstrate that cooperativity requires the N-terminal leucine-rich repeat-targeting domain and is transduced through Phe(395). Additionally, these mechanistic features are conserved in a distantly related SspH2 Salmonella enterica ligase. Kinetic parallels between IpaH9.8 and the recently revised mechanism for E6AP/UBE3A (Ronchi, V. P., Klein, J. M., and Haas, A. L. (2013) E6AP/UBE3A ubiquitin ligase harbors two E2∼ubiquitin binding sites. J. Biol. Chem. 288, 10349-10360) suggest convergent evolution of the catalytic mechanisms for prokaryotic and eukaryotic ligases.


Asunto(s)
Antígenos Bacterianos/química , Proteínas Bacterianas/química , Poliubiquitina/metabolismo , Subunidades de Proteína/química , Shigella flexneri/química , Ubiquitina-Proteína Ligasas/química , Regulación Alostérica , Sitio Alostérico , Antígenos Bacterianos/genética , Antígenos Bacterianos/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Unión Competitiva , Escherichia coli/genética , Escherichia coli/metabolismo , Evolución Molecular , Expresión Génica , Radioisótopos de Yodo , Cinética , Modelos Moleculares , Mutación , Poliubiquitina/genética , Unión Proteica , Multimerización de Proteína , Subunidades de Proteína/genética , Subunidades de Proteína/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Shigella flexneri/enzimología , Transducción de Señal , Especificidad por Sustrato , Ubiquitina-Proteína Ligasas/genética , Ubiquitina-Proteína Ligasas/metabolismo
5.
J Biol Chem ; 289(2): 1033-48, 2014 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-24273172

RESUMEN

Employing 125I-polyubiquitin chain formation as a functional readout of ligase activity, biochemical and biophysical evidence demonstrates that catalytically active E6-associated protein (E6AP)/UBE3A is an oligomer. Based on an extant structure previously discounted as an artifact of crystal packing forces, we propose that the fully active form of E6AP is a trimer, analysis of which reveals a buried surface of 7508Å2 and radially symmetric interacting residues that are conserved within the Hect (homologous to E6AP C terminus) ligase superfamily. An absolutely conserved interaction between Phe(727) and a hydrophobic pocket present on the adjacent subunit is critical for trimer stabilization because mutation disrupts the oligomer and decreases kcat 62-fold but fails to affect E2 ubiquitin binding or subsequent formation of the Hect domain Cys(820) ubiquitin thioester catalytic intermediate. Exogenous N-acetylphenylalanylamide reversibly antagonizes Phe(727)-dependent trimer formation and catalytic activity (Ki12 mM), as does a conserved-helical peptide corresponding to residues 474­490 of E6A Pisoform 1 (Ki22M) reported to bind the hydrophobic pocket of other Hect ligases, presumably blocking Phe(727) intercalation and trimer formation. Conversely, oncogenic human papillomavirus-16/18 E6 protein significantly enhances E6AP catalytic activity by promoting trimer formation (Kactivation 1.5 nM) through the ability of E6 to form homodimers. Recombinant E6 protein additionally rescues the kcat defect of the Phe(727) mutation and that of a specific loss-of-function Angelman syndrome mutation that promotes trimer destabilization. The present findings codify otherwise disparate observations regarding the mechanism of E6AP and related Hect ligases in addition to suggesting therapeutic approaches for modulating ligase activity.


Asunto(s)
Multimerización de Proteína , Estructura Terciaria de Proteína , Ubiquitina-Proteína Ligasas/química , Ubiquitina-Proteína Ligasas/metabolismo , Secuencia de Aminoácidos , Síndrome de Angelman/genética , Síndrome de Angelman/metabolismo , Animales , Sitios de Unión/genética , Biocatálisis , Electroforesis en Gel de Poliacrilamida , Humanos , Enlace de Hidrógeno , Radioisótopos de Yodo , Isoenzimas/química , Isoenzimas/genética , Isoenzimas/metabolismo , Cinética , Modelos Moleculares , Datos de Secuencia Molecular , Mutación , Filogenia , Poliubiquitina/metabolismo , Estructura Secundaria de Proteína , Homología de Secuencia de Aminoácido , Células Sf9 , Ubiquitina/metabolismo , Ubiquitina-Proteína Ligasas/genética
7.
FEBS J ; 279(7): 1243-51, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22314229

RESUMEN

Filamentous marine cyanobacteria are extremely rich sources of bioactive natural products and often employ highly unusual biosynthetic enzymes in their assembly. However, the current lack of techniques for stable DNA transfer into these filamentous organisms, combined with the absence of heterologous expression strategies for nonribosomal cyanobacterial gene clusters, prohibit the creation of mutant strains or the heterologous production of these cyanobacterial compounds in other bacteria. In this study, we evaluated the capability of a derivative of the model actinomycete Streptomyces coelicolor A3(2) to express enzymes involved in the biosynthesis of the protein kinase C activator lyngbyatoxin A from a Hawaiian strain of Moorea producta (previously classified as Lyngbya majuscula). Despite large differences in GC content between these two bacteria and the presence of rare TTA/UUA leucine codons in lyngbyatoxin ORFs we were able to achieve expression of the cytochrome P450 monooxygenase LtxB and reverse prenyltransferase LtxC in S. coelicolor M512 and confirmed the in vitro functionality of S. coelicolor overexpressed LtxC. Attempts to express the entire lyngbyatoxin A gene cluster in S. coelicolor M512 were not successful because of transcript termination observed for the ltxA gene, which encodes a large nonribosomal peptide synthetase. However, these attempts did show a detectable level of cyanobacterial promoter recognition in Streptomyces. Successful expression of lyngbyatoxin A proteins in Streptomyces provides a new platform for biochemical investigation of natural product enzymes from Moorea strains.


Asunto(s)
Proteínas Bacterianas/metabolismo , Cianobacterias/genética , Cianobacterias/metabolismo , Toxinas de Lyngbya/metabolismo , Proteína Quinasa C/metabolismo , Streptomyces coelicolor/genética , Streptomyces coelicolor/metabolismo , Proteínas Bacterianas/genética , Productos Biológicos/química , Productos Biológicos/metabolismo , Cianobacterias/química , Regulación Bacteriana de la Expresión Génica , Genes Bacterianos , Toxinas de Lyngbya/química , Estructura Molecular , Familia de Multigenes , Sistemas de Lectura Abierta , Proteína Quinasa C/genética
8.
J Nat Prod ; 73(1): 71-4, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20000453

RESUMEN

The P450 cytochrome monooxygenase gene, ltxB, was cloned and overexpressed in Escherichia coli as a 6xHis-tagged protein. The resulting recombinant LtxB was purified by Ni-NTA affinity chromatography and characterized biochemically. Purified LtxB demonstrated typical cytochrome P450 spectroscopic properties including substrate-induced transition from a low-spin (lambdamax=414 nm) to high-spin state (lambdamax=386 nm) upon incubation with N-methyl-L-valyl-L-tryptophanol. The catalytic activity of LtxB was verified by demonstrating the oxidation/cyclization of N-methyl-L-valyl-L-tryptophanol to (-)-indolactam V. LtxB shows a relaxed specificity for analogue substrates in which the valyl group is substituted for other aliphatic groups. The relaxed substrate specificity of LtxB, along with the relaxed specificity of the prenyltransferase, LtxC, allowed for the enzymatic production of a series of (-)-indolactam V and lyngbyatoxin analogues.


Asunto(s)
Sistema Enzimático del Citocromo P-450/genética , Sistema Enzimático del Citocromo P-450/metabolismo , Indoles/metabolismo , Lactamas/metabolismo , Toxinas de Lyngbya/genética , Secuencia de Bases , Escherichia coli/genética , Escherichia coli/metabolismo , Indoles/química , Indoles/aislamiento & purificación , Lactamas/química , Lactamas/aislamiento & purificación , Toxinas de Lyngbya/aislamiento & purificación , Toxinas de Lyngbya/metabolismo , Estructura Molecular , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Estereoisomerismo , Relación Estructura-Actividad , Especificidad por Sustrato
9.
Eukaryot Cell ; 7(12): 2078-86, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18849469

RESUMEN

Chromosomal sites of RNA polymerase III (Pol III) transcription have been demonstrated to have "extratranscriptional" functions, as the assembled Pol III complex can act as chromatin boundaries or pause sites for replication forks, can alter nucleosome positioning or affect transcription of neighboring genes, and can play a role in sister chromatid cohesion. Several studies have demonstrated that assembled Pol III complexes block the propagation of heterochromatin-mediated gene repression. Here we show that in Saccharomyces cerevisiae tRNA genes (tDNAs) and even partially assembled Pol III complexes containing only the transcription factor TFIIIC can exhibit chromatin boundary functions both as heterochromatin barriers and as insulators to gene activation. Both the TRT2 tDNA and the ETC4 site which binds only the TFIIIC complex prevented an upstream activation sequence from activating the GAL promoters in our assay system, effectively acting as chromatin insulators. Additionally, when placed downstream from the heterochromatic HMR locus, ETC4 blocked the ectopic spread of Sir protein-mediated silencing, thus functioning as a barrier to repression. Finally, we show that TRT2 and the ETC6 site upstream of TFC6 in their natural contexts display potential insulator-like functions, and ETC6 may represent a novel case of a Pol III factor directly regulating a Pol II promoter. The results are discussed in the context of how the TFIIIC transcription factor complex may function to demarcate chromosomal domains in yeast and possibly in other eukaryotes.


Asunto(s)
Cromatina/metabolismo , Heterocromatina/metabolismo , Elementos Aisladores , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Factores de Transcripción TFIII/genética , Sitios de Unión , Unión Proteica , ARN Polimerasa III/genética , ARN Polimerasa III/metabolismo , ARN de Transferencia/genética , ARN de Transferencia/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/metabolismo , Factores de Transcripción TFIII/metabolismo
10.
J Nat Prod ; 71(1): 22-7, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18163584

RESUMEN

Investigation of a Symploca sp. from Papua New Guinea has led to the isolation of symplocamide A (1), a potent cancer cell cytotoxin, which also inhibits serine proteases with a 200-fold greater inhibition of chymotrypsin over trypsin. The complete stereostructure of symplocamide A was determined by detailed NMR and MS analysis as well as chiral HPLC analysis of the component amino acid residues. The presence of several unusual structural features in symplocamide A provides new insights into the pharmacophore model for protease selectivity in this drug class and may underlie the potent cytotoxicity of this compound to H-460 lung cancer cells (IC50=40 nM) as well as neuro-2a neuroblastoma cells (IC50=29 nM).


Asunto(s)
Antineoplásicos/aislamiento & purificación , Antineoplásicos/farmacología , Quimotripsina/antagonistas & inhibidores , Cianobacterias/química , Citotoxinas/aislamiento & purificación , Citotoxinas/farmacología , Depsipéptidos/aislamiento & purificación , Depsipéptidos/farmacología , Toxinas Marinas/aislamiento & purificación , Toxinas Marinas/farmacología , Animales , Antineoplásicos/química , Citotoxinas/química , Depsipéptidos/química , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Leishmania donovani/efectos de los fármacos , Toxinas Marinas/química , Estructura Molecular , Papúa Nueva Guinea , Plasmodium falciparum/efectos de los fármacos , Trypanosoma cruzi/efectos de los fármacos
11.
Biochemistry ; 45(6): 1537-46, 2006 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-16460000

RESUMEN

For screening a pool of potential substrates that load carrier domains found in nonribosomal peptide synthetases, large molecule mass spectrometry is shown to be a new, unbiased assay. Combining the high resolving power of Fourier transform mass spectrometry with the ability of adenylation domains to select their own substrates, the mass change that takes place upon formation of a covalent intermediate thus identifies the substrate. This assay has an advantage over traditional radiochemical assays in that many substrates, the substrate pool, can be screened simultaneously. Using proteins on the nikkomycin, clorobiocin, coumermycin A1, yersiniabactin, pyochelin, and enterobactin biosynthetic pathways as proof of principle, preferred substrates are readily identified from substrate pools. Furthermore, this assay can be used to provide insight into the timing of tailoring events of biosynthetic pathways as demonstrated using the bromination reaction found on the jamaicamide biosynthetic pathway. Finally, this assay can provide insight into the role and function of orphan gene clusters for which the encoded natural product is unknown. This is demonstrated by identifying the substrates for two NRPS modules from the pksN and pksJ genes that are found on an orphan NRPS/PKS hybrid cluster from Bacillus subtilis. This new assay format is especially timely for activity screening in an era when new types of thiotemplate assembly lines that defy classification are being discovered at an accelerating rate.


Asunto(s)
Espectrometría de Masas/métodos , Péptido Sintasas/metabolismo , Adenosina Trifosfato/metabolismo , Aminocumarinas/química , Aminocumarinas/metabolismo , Aminoglicósidos/química , Aminoglicósidos/metabolismo , Bacillus subtilis/enzimología , Bacillus subtilis/genética , Bromo/química , Bromo/metabolismo , Dominio Catalítico , Enterobactina/química , Enterobactina/metabolismo , Familia de Multigenes , Novobiocina/análogos & derivados , Novobiocina/química , Novobiocina/metabolismo , Péptido Sintasas/química , Fenoles/química , Fenoles/metabolismo , Pirrolidinonas/química , Pirrolidinonas/metabolismo , Especificidad por Sustrato , Compuestos de Sulfhidrilo/química , Compuestos de Sulfhidrilo/metabolismo , Tiazoles/química , Tiazoles/metabolismo
12.
J Am Chem Soc ; 126(37): 11432-3, 2004 Sep 22.
Artículo en Inglés | MEDLINE | ID: mdl-15366877

RESUMEN

The lyngbyatoxins are potent skin irritants produced by Lyngbya majuscula and cause a condition known as "Swimmer's Itch" off Honolulu, HI. Reported is the molecular cloning of the lyngbyatoxin (ltx) biosynthetic gene cluster from L. majuscula using a strategy based on its predicted nonribosomal peptide synthetase (NRPS) assembly. The biosynthetic gene cluster spans 11.3 kilobase pairs and encodes for a two-module NRPS (LtxA), a P450 monooxygenase (LtxB), an aromatic prenyltransferase (LtxC), and an oxidase/reductase protein (LtxD). LtxC was heterologously produced and purified from E. coli and shown to catalyze the transfer of a geranyl group to (-)-indolactam V as the final step in the biosynthesis of lyngbyatoxin A.


Asunto(s)
Cianobacterias/enzimología , Cianobacterias/genética , Dimetilaliltranstransferasa/metabolismo , Toxinas de Lyngbya/biosíntesis , Toxinas de Lyngbya/genética , Clonación Molecular , Cianobacterias/metabolismo , Dimetilaliltranstransferasa/genética , Indoles/química , Indoles/metabolismo , Lactamas/química , Lactamas/metabolismo , Familia de Multigenes
13.
Chem Biol ; 11(6): 817-33, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15217615

RESUMEN

A screening program for bioactive compounds from marine cyanobacteria led to the isolation of jamaicamides A-C. Jamaicamide A is a novel and highly functionalized lipopeptide containing an alkynyl bromide, vinyl chloride, beta-methoxy eneone system, and pyrrolinone ring. The jamaicamides show sodium channelblocking activity and fish toxicity. Precursor feeding to jamaicamide-producing cultures mapped out the series of acetate and amino acid residues and helped develop an effective cloning strategy for the biosynthetic gene cluster. The 58 kbp gene cluster is composed of 17 open reading frames that show an exact colinearity with their expected utilization. A novel cassette of genes appears to form a pendent carbon atom possessing the vinyl chloride functionality; at its core this contains an HMG-CoA synthase-like motif, giving insight into the mechanism by which this functional group is created.


Asunto(s)
Amidas/química , Cianobacterias/química , Toxinas Marinas/química , Neurotoxinas/química , Péptidos/química , Pirrolidinonas/química , Amidas/aislamiento & purificación , Amidas/farmacología , Animales , Secuencia de Bases , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Cianobacterias/genética , Cianobacterias/metabolismo , Humanos , Lipopéptidos , Lipoproteínas/química , Lipoproteínas/aislamiento & purificación , Lipoproteínas/farmacología , Toxinas Marinas/aislamiento & purificación , Toxinas Marinas/farmacología , Ratones , Datos de Secuencia Molecular , Estructura Molecular , Familia de Multigenes , Neurotoxinas/aislamiento & purificación , Neurotoxinas/farmacología , Péptidos/aislamiento & purificación , Péptidos/farmacología , Estructura Terciaria de Proteína , Pirrolidinonas/aislamiento & purificación , Pirrolidinonas/farmacología , Canales de Sodio/efectos de los fármacos , Canales de Sodio/fisiología
14.
J Nat Prod ; 65(3): 422-31, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11908996

RESUMEN

Bleomycin (BLM) biosynthesis has been studied as a model for hybrid peptide-polyketide natural product biosynthesis. Cloning, sequencing, and biochemical characterization of the blm biosynthetic gene cluster from Streptomyces verticillus ATCC15003 revealed that (1) the BLM hybrid peptide-polyketide aglycon is assembled by the BLM megasynthetase that consists of both nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) modules; (2) BlmIX/BlmVIII/BlmVII constitute a natural hybrid NRPS/PKS/NRPS system, serving as a model for both hybrid NRPS/PKS and PKS/NRPS systems; (3) the catalytic sites appear to be conserved in both hybrid NRPS/PKS and nonhybrid NRPS or PKS systems, with the exception of the KS domains in the hybrid NRPS/PKS systems that are unique; (4) specific interpolypeptide linkers may play a critical role in intermodular communication to facilitate the transfer of the growing intermediates between the interacting NRPS and/or PKS modules; (5) post-translational modification of the BLM megasynthetase has been accomplished by a single PPTase with broad carrier protein specificity; and (6) BlmIV/BlmIII-templated assembly of the BLM bithiazole moiety requires intriguing protein juxtaposition and modular recognition. These results lay the foundation to investigate the molecular basis for intermodular communication between NRPS and PKS in hybrid peptide-polyketide natural product biosynthesis and set the stage for engineering novel BLM analogues by genetic manipulation of genes governing BLM biosynthesis.


Asunto(s)
Antibióticos Antineoplásicos/biosíntesis , Factores Biológicos/biosíntesis , Bleomicina/biosíntesis , Complejos Multienzimáticos/metabolismo , Péptido Sintasas/metabolismo , Streptomyces , Biotecnología/métodos , Catálisis , Genes Bacterianos , Modelos Químicos , Estructura Molecular , Complejos Multienzimáticos/genética , Familia de Multigenes , Streptomyces/enzimología , Streptomyces/genética , Streptomyces/metabolismo , Especificidad por Sustrato
15.
Acad Emerg Med ; 9(1): 22-6, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11772665

RESUMEN

OBJECTIVE: To compare the frequencies with which suburban and urban parents give their children antibiotics without first consulting a physician. METHODS: This was a prospective, comparative survey of a suburban emergency department (ED) patient population in New Jersey with an annual patient census of 60,000 visits and an urban ED in Connecticut with 58,000 annual visits. A convenience sample of parents with children <18 years of age were enrolled. Patients who were critically ill and/or not oriented were excluded. Subjects provided written answers to a series of closed questions regarding their knowledge and use of antibiotics for their children over the previous 12 months. Categorical data were analyzed by chi-square and Fisher's exact test; continuous data were analyzed by t-tests. All tests were two-tailed with alpha set at 0.05. The primary endpoint, antibiotic "misuse," was defined as parental administration of antibiotics to a child during the previous 12 months without the consultation of a physician. RESULTS: Eight hundred one parents were enrolled; 424 at the suburban site. Parents in the suburban site were significantly different with regard to mean age (39 +/- 7.2 vs. 32 +/- 9.0, p < 0.001), percentage female sex (63% vs. 81%, p < 0.001), percentage white race (78% vs. 34%, p < 0.001), and percentage with private insurance (89% vs. 56%, p < 0.001). A higher percentage of parents at the suburban site had misused antibiotics (12.1% vs. 4.0%; p < 0.001). Using logistic regression, this significant difference in the rate of antibiotic misuse between the two groups remained after adjustment for demographic variables and insurance status of the parents (p < 0.001). Parents at the suburban site were significantly less likely to have been previously discharged with their child from an office or ED setting without antibiotics only to go soon afterwards to another health facility in order to obtain such medications (5% vs. 48%; p < 0.001). CONCLUSIONS: Parents in the suburban setting were more likely to have misused antibiotics for their children. On the other hand, parents in the urban setting were more likely to have been discharged by a physician at one health facility and gone to another physician's office or ED in order to obtain antibiotics for their children.


Asunto(s)
Antibacterianos/administración & dosificación , Infecciones Bacterianas/tratamiento farmacológico , Población Rural , Automedicación/estadística & datos numéricos , Población Urbana , Adulto , Factores de Edad , Niño , Preescolar , Intervalos de Confianza , Connecticut , Recolección de Datos , Servicio de Urgencia en Hospital , Femenino , Encuestas Epidemiológicas , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , New Jersey , Relaciones Padres-Hijo , Padres , Probabilidad , Estudios Prospectivos , Muestreo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...